بناءً على طلبكم، تم تمديد طلب الانضمام في #جمعية_التيقظ_الدوائي إلى: يوم السبت 19 أكتوبر 2024 الساعة 11:59 مساءً 🔗: docs.google.com/forms/d/e/1FAI…

In July 2022, #Gambia faced a tragic spike in acute kidney injuries among children, linked to contaminated medicines. WHO’s swift response, a nationwide recall and global alerts prevented further outbreaks in countries like Cambodia and Uzbekistan. WHO demonstrates how a

🚀 To Vigi and beyond! UMC makes a free national toolkit for safety surveillance available to all members of the World Health Organization (WHO) PIDM. Take an intergalactic journey through the VIGIVERSE🪐 in the thread below to learn more about #VigiFlow and connected Vigi applications👇

Job opportunity in pharmacovigilance: itg.be/en/jobs-and-re…

There are still risks with overrelying on ChatGPT to answer medical and pharmaceutical questions: Morath B, et al. Performance and risks of ChatGPT used in drug information: an exploratory real-world analysis. EU J Hospital Pharmacy. 2023 May 31. pubmed.ncbi.nlm.nih.gov/37263772/

#MedSafetyWeek starts today. All medicines can cause side effects. You can help prevent them by taking your medicines as instructed. Take your medicines in the right dose, at the right time, and in the right way.

من أكثر الآثار الجانبية المرافقة للأدوية التي تؤخذ بالفم هي المتعلقة بالهضم كالغثيان والقيء والإسهال أما أدوية الاستخدام الخارجي كالمراهم والدهون فيكون التهيج الجلدي هو الأثر الجانبي الأكثر حدوثا. "أسبوع ضرورة الإبلاغ عن الآثار الجانبية للأدوية"  #صحة_رائدة_مستدامة_للجميع

As #FightTheFakes Week concludes, continue to report #FakeMeds to keep patients safe and secure the global medicines supply chain. 📖 Read the Fight the Fakes Alliance newsletter for more in-depth stories on how partners are working to #StopFakeMeds worldwide 👉 ow.ly/Cqay50Un1Ho

Today the #NobelPrize award ceremony takes place in Stockholm🇸🇪. We explore the Nobel connection between our vigiGroup method and the #NeuralNetworks pioneered by one of this year's laureates in #UppsalaReports. Read the full article at the link below👇 uppsalareports.org/articles/from-…

Medication errors significantly contribute to the global numbers of ADRs per year. How can we best prepare the #pharmacovigilance community to tackle the problem of #MedicationErrors? Find out in the latest print issue of #UppsalaReports 👉 ow.ly/gj6Y50Umm0c

📢 Help shape medication safety in the Gulf Cooperation Council (GCC) 🇰🇼🇸🇦🇧🇭🇶🇦🇴🇲🇦🇪 Join our Delphi study to set research priorities in #MedicationSafety and pharmacovigilance in the GCC region. ✅ GCC-based experts with 2+ publications 📲 Scan the QR code in the image to join!

Pharmaceutical Manufacturers and Distributors: Responsibility is not an option—it’s a commitment. #PPBCares

Want to learn more about #ISoPOnline's PV in the Community SIG? 🌍 Check out the latest article in Drug Safety Journal to discover its mandate, strategies, and vital role in patient safety. Read it here: link.springer.com/article/10.100… #Pharmacovigilance #PatientSafety

We're excited to announce that Dr. Reem Al-Essa, Director of #DrugInspection Administration | #Pharmacovigilance Superintendent - وزارة الصحة , will be one of the #speakers at the #GCCPharmacovigilanceTraining this year! pramagcc.com/pv #GCCPVTraining #Kuwait #Regulation

🚀 To Vigi and beyond! UMC makes a free national toolkit for safety surveillance available to all members of the World Health Organization (WHO) PIDM. Take an intergalactic journey through the VIGIVERSE🪐 in the thread below to learn more about #VigiFlow and connected Vigi applications👇

See (NEJM) recent review on DRESS syndrome—crucial topic for the public and medical providers! Paper covers: 🔍 Symptoms & Diagnostic Clues 💊 Drug Culprits ⚕️ Treatment Protocols 🔗 ow.ly/Z46y50UIPmE #DRESSsyndrome #DrugReactions #Dermatology #Allergy #Immunology

Read our latest paper on Empowering African expertise in signal management, published with Springer Nature in Drug Safety.Read hear zaf01.safelinks.protection.outlook.com/?url=https%3A%… Uganda National Drug Authority Dan Kajungu, PhD AUDA-NEPAD Dan Kajungu, PhD Albert Figueras

Interested in #DrugSafety? Have you considered becoming a member of ISoP and benefit from a special rate for your registration to the Eu2P Master in #Pharmacovigilance and #Pharmacoepidemiology?

Don't Miss this Informative Session on SJS/TEN & DRESS Syndrome! Join us:: Feb 25, 7-9 PM ET via Zoom! Learn about these severe drug reaction. Hear from medical experts, advocacy foundations & survivors. 🔑 FREE Event! 🔗 Register: sjscanada.org/sjs-events #SJS #DRESSSyndrome

🚀 **Strengthening Vaccine Safety in Uganda** major milestone in pharmacovigilance as global and national partners—WHO , UMC-WHO PIDM, EPI, and MOH collaborate at the VigiMobile, digital safety surveillance tool. 📲 Better AEFI reporting 🌍 Global expertise meets local